These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

932 related items for PubMed ID: 1351780

  • 21. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ, Marshall JF.
    Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
    [Abstract] [Full Text] [Related]

  • 22. Motor activation in short- and long-term reserpinized mice: role of N-methyl-D-aspartate, dopamine D1 and dopamine D2 receptors.
    Ferré S, Giménez-Llort L, Artigas F, Martínez E.
    Eur J Pharmacol; 1994 Apr 01; 255(1-3):203-13. PubMed ID: 7913043
    [Abstract] [Full Text] [Related]

  • 23. D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease.
    Paul ML, Graybiel AM, David JC, Robertson HA.
    J Neurosci; 1992 Oct 01; 12(10):3729-42. PubMed ID: 1357113
    [Abstract] [Full Text] [Related]

  • 24. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT, White FJ.
    Synapse; 1992 Mar 01; 10(3):206-16. PubMed ID: 1532677
    [Abstract] [Full Text] [Related]

  • 25. The actions of (-)N-n-propylnorapomorphine and selective dopamine D1 and D2 receptor agonists to modify the release of [3H]dopamine from the rat nucleus accumbens.
    Barnes JM, Barnes NM, Costall B, Naylor RJ.
    Neuropharmacology; 1990 Apr 01; 29(4):327-36. PubMed ID: 1971430
    [Abstract] [Full Text] [Related]

  • 26. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
    Wachtel SR, Hu XT, Galloway MP, White FJ.
    Synapse; 1989 Apr 01; 4(4):327-46. PubMed ID: 2532422
    [Abstract] [Full Text] [Related]

  • 27. Differential regulation of striatal preproenkephalin mRNA by D1 and D2 dopamine receptors.
    Pollack AE, Wooten GF.
    Brain Res Mol Brain Res; 1992 Jan 01; 12(1-3):111-9. PubMed ID: 1312196
    [Abstract] [Full Text] [Related]

  • 28. Stimulation of D2-receptors in rat nucleus accumbens slices inhibits dopamine and acetylcholine release but not cyclic AMP formation.
    Stoof JC, Verheijden PF, Leysen JE.
    Brain Res; 1987 Oct 13; 423(1-2):364-8. PubMed ID: 2823991
    [Abstract] [Full Text] [Related]

  • 29. The role of D1 and D2 dopamine receptors in oral stereotypy induced by dopaminergic stimulation of the ventrolateral striatum.
    Delfs JM, Kelley AE.
    Neuroscience; 1990 Oct 13; 39(1):59-67. PubMed ID: 1982467
    [Abstract] [Full Text] [Related]

  • 30. Effect of dopamine D-1 and D-2 receptor selective drugs on dopamine release and metabolism in rat striatum in vivo.
    Zetterström T, Sharp T, Ungerstedt U.
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Oct 13; 334(2):117-24. PubMed ID: 2946964
    [Abstract] [Full Text] [Related]

  • 31. Dopamine D2 receptors exert tonic regulation over discrete neurotensin systems of the rat brain.
    Merchant KM, Bush LG, Gibb JW, Hanson GR.
    Brain Res; 1989 Oct 23; 500(1-2):21-9. PubMed ID: 2532557
    [Abstract] [Full Text] [Related]

  • 32. Dissimilarities between cholinergic and dopaminergic turning elicited by nucleus accumbens stimulation in freely moving rats.
    Saigusa T, Koshikawa N, Kitamura M, Mizutani K, Kobayashi M, Cools AR.
    Eur J Pharmacol; 1995 Feb 14; 274(1-3):213-20. PubMed ID: 7539377
    [Abstract] [Full Text] [Related]

  • 33. The effect of dopamine D1 and D2 receptor agonists on inositol phosphate turnover in rat striatal slices.
    Gupta SK, Mishra RK.
    Biochem Int; 1990 Dec 14; 22(5):887-94. PubMed ID: 1983069
    [Abstract] [Full Text] [Related]

  • 34. Modulation of acetylcholine release by D1, D2 dopamine receptors in rat striatum under freely moving conditions.
    Ajima A, Yamaguchi T, Kato T.
    Brain Res; 1990 Jun 04; 518(1-2):193-8. PubMed ID: 1975213
    [Abstract] [Full Text] [Related]

  • 35. Selective unilateral inactivation of striatal D1 and D2 dopamine receptor subtypes by EEDQ: turning behavior elicited by D2 dopamine receptor agonists.
    Giorgi O, Biggio G.
    Brain Res; 1990 Nov 12; 533(1):53-9. PubMed ID: 1982234
    [Abstract] [Full Text] [Related]

  • 36. Discriminatory roles for D1 and D2 dopamine receptor subtypes in the in vivo control of neostriatal cyclic GMP.
    Altar CA, Boyar WC, Kim HS.
    Eur J Pharmacol; 1990 May 31; 181(1-2):17-21. PubMed ID: 1974856
    [Abstract] [Full Text] [Related]

  • 37. Striatal Fos expression is indicative of dopamine D1/D2 synergism and receptor supersensitivity.
    LaHoste GJ, Yu J, Marshall JF.
    Proc Natl Acad Sci U S A; 1993 Aug 15; 90(16):7451-5. PubMed ID: 8102797
    [Abstract] [Full Text] [Related]

  • 38. The role of NMDA receptor systems in neuropeptide responses to stimulants of abuse.
    Hanson GR, Singh N, Merchant K, Johnson M, Gibb JW.
    Drug Alcohol Depend; 1995 Feb 15; 37(2):107-10. PubMed ID: 7758400
    [Abstract] [Full Text] [Related]

  • 39. N-methyl-D-aspartate receptor blockade attenuates D1 dopamine receptor modulation of neuronal activity in rat substantia nigra.
    Huang KX, Bergstrom DA, Ruskin DN, Walters JR.
    Synapse; 1998 Sep 15; 30(1):18-29. PubMed ID: 9704877
    [Abstract] [Full Text] [Related]

  • 40. Hemispheric asymmetry in behavioral response to D1 and D2 receptor agonists in the nucleus accumbens.
    Belcheva I, Bryer JB, Starkstein SE, Honig M, Moran TH, Robinson RG.
    Brain Res; 1990 Nov 19; 533(2):286-91. PubMed ID: 1981170
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 47.